Overview

Dashboard News

eni lowers profit forecast amid declining oil prices and refining margins

Eni SpA has revised its profit guidance downward due to a deteriorating outlook for oil prices, despite reporting third-quarter earnings that surpassed analyst expectations. The results reflect a challenging environment for Europe's energy sector, characterized by declining crude prices and reduced margins in refining and chemical products.
bloomberg.com
Eni S.p.A. ITA
Finance & Economy, Market Report
07:41 25.10.2024

mid-cap stocks in india face correction amid slowing growth concerns

Mid-cap stocks in India are facing a correction as concerns over slowing earnings growth and high valuations mount. The Nifty Midcap 100 index fell 2.9% on Friday, marking a decline of over 10% from its recent peak, driven by significant selling from foreign portfolio managers after a 30% rally through September 23.
bloomberg.com
Nifty Midcap 100 IND
Finance & Economy, Market Report
07:39 25.10.2024

China's economic stimulus impacts Indian equities and investor sentiment

Markets have struggled to recover, raising concerns for investors. Earlier this month, it was noted that the improving conditions in China's stock markets could negatively impact Indian equities. Following a hazy economic stimulus announcement from China, its undervalued markets attracted investor interest.
Moneycontrol
Chinese Yuan IND CHN
Finance & Economy, Market Report
07:37 25.10.2024

colgate palmolive shares drop as margin decline overshadows profit growth

Colgate-Palmolive India reported a net profit of Rs 395.05 crore for Q2, marking a 16.2% year-on-year increase, driven by broad-based portfolio growth. However, sales rose 10.04% to Rs 1,609.21 crore, while EBITDA growth was only 3%, attributed to a 205 basis points decline in margins amid a challenging demand environment and high promotional intensity.
Moneycontrol
Indian Rupee Colgate-Palmolive (India) Limited IND
Finance & Economy, Market Report
07:37 25.10.2024

lucerne bank reports strong growth and optimistic outlook for 2024

Luzerner Kantonalbank (LUKB) reported a strong performance in the first nine months of the year, with customer advances rising 3.0% to CHF 42.98 billion and net profit increasing 9.1% to CHF 216.0 million, bolstered by the sale of its stake in Fundamenta. Despite a decline in trading revenues, the bank's operating income grew by 5.7% to CHF 483.5 million, and management aims for a profit target of CHF 270 to 280 million for 2024, focusing on enhancing non-interest income and loan growth.
Allnews
Swiss Franc Luzerner Kantonalbank AG CHE Daniel Salzmann
TradFi, Market Report
07:36 25.10.2024

China announces export controls on military goods amid Ukraine conflict tensions

China's Ministry of Commerce has announced new export controls on dual-use items, set to take effect on December 1, amid Western scrutiny over its ties with Russia during the Ukraine war. While emphasizing its commitment to restrict military goods exports, Beijing maintains that its support for Moscow is not unlimited. The regulations aim to enhance oversight of drone exports and align with international norms, yet they leave room for continued economic cooperation with Russia.
CNBC
United States Dollar DJI Technology Co. UKR USA RUS CHN He Yadong Sari Arho Havren Gabriel Wildau Xi Jinping Vladimir Putin Show more
Regulatory & Legal, News Article
07:34 25.10.2024

sanofi reports profit increase driven by strong vaccine sales and dupixent growth

Sanofi reported a profit increase driven by strong demand for seasonal vaccines and growth in its leading therapies, particularly Dupixent for skin and asthma conditions. In the third quarter, earnings per share, excluding certain items, reached €2.86 ($3.10), surpassing analysts' expectations, bolstered by early sales of influenza and respiratory syncytial virus vaccines.
bloomberg.com
United States Dollar Euro Sanofi FRA
Healthcare, Market Report
07:32 25.10.2024

hedge funds suffer losses from failed china drugmaker deal

Millennium Management and Athos Capital Ltd. have incurred losses following the unexpected collapse of a deal involving two Chinese drugmakers. Millennium held a 5.1% stake in China Traditional Chinese Medicine Holdings Co., which plummeted 35% after regulators rejected a take-private offer from China National Pharmaceutical Group Co. Both firms have since reduced their holdings.
bloomberg.com
Chinese Yuan China National Pharmaceutical Group Corp. Millennium Management Inc. CHN China National Pharmaceutical Group Co. Izzy Englander
Finance & Economy, Market Report
07:32 25.10.2024

switzerland faces challenges with ubss size and regulatory pressures

Switzerland faces a critical juncture regarding UBS, whose total assets are nearly double the nation's GDP, raising concerns about systemic risk. As regulatory pressures mount, questions arise about the country's willingness to maintain a major global bank or suggest UBS relocate abroad. The ongoing debate highlights the tension between safeguarding the financial sector and the realities of international competition.
Neue Zürcher Zeitung
Swiss Franc Zürcher Kantonalbank UBS AG Credit Suisse Anlagestiftung CHE USA Karin Keller-Sutter Gerhard Pfister Sergio Ermotti Show more
Finance & Economy, Market Report
07:30 25.10.2024

remy cointreau lowers sales forecast amid declining us and china demand

Remy Cointreau SA has cut its annual sales guidance due to weak demand in the US and China, where consumer spending remains low. The French Cognac maker now expects organic sales to decline by double digits this year, with a 16.1% drop reported for the second quarter ending September, surpassing estimates.
bloomberg.com
Rémy Cointreau SA FRA USA CHN Show more
Finance & Economy, Market Report
07:29 25.10.2024
Trending
Subcategory:
Stock Market Updates Industry Trends Corporate News Retail and Consumer Goods Banking Regulations European Securities and Markets Authority Global Financial Events Finance Mergers & Acquisitions Industry Mergers & Acquisitions Market Analysis and Predictions Central Bank Actions Supply Chain Management Inflation and Monetary Impact CEO Changes Bond Market & Treasury Yields Banking & Investment Regulations Financial Scams and Security Foreign Exchange Rates Workplace Trends Government Economic Policies
Countries:
USA CHE CHN DEU GBR FRA SGP IND SWE HKG JPN CAN TWN AUS MEX AUT KOR ITA LUX ARG
Companies:
Apple Inc. Credit Suisse High Yield Bond Fund, Inc. Vivos Inc. UBS Group AG Zalando SE Compagnie de Saint-Gobain S.A. IG Group Holdings plc JPMorgan Chase & Co. XIAOMI-W Samsung Biologics Co.,Ltd. Tesmec S.p.A. UBS AG Spotify Technology S.A. Michelin Berner Kantonalbank AG Siemens Energy AG Thurgauer Kantonalbank SAP SE RICHEMONT, Intellectual Property Services Taiwan Semiconductor Manufacturing Co Ltd
Currencies:
United States Dollar Euro Swiss Franc Chinese Yuan British Pound Sterling Indian Rupee New Zealand Dollar Australian Dollar New Taiwan Dollar South Korean Won Danish Krone Singapore Dollar Japanese Yen Argentine Peso Indonesian Rupiah Vietnamese Đồng Canadian Dollar Malaysian Ringgit Hong Kong Dollar
People:
Donald Trump Viktor Nebehaj Amber Liu Andre Kukhnin Joe Biden David Lesne Zuzanna Pusz Breon Corcoran Yashraj Rajani Warren Buffett Gregor Kuglitsch Thomas Müller Manik Narain Graham Doyle Alan Estevez Toby Zhu Hubert Dichtl Guillaume Delmas Carsten Spohr Chris Sanders

Machinary offers a groundbreaking, modular, and customizable solution that provides advanced financial news and statistical analysis. Our platform goes beyond traditional quantitative analysis, offering users a comprehensive understanding of real-time market dynamics, event detection, and risk analysis.

Links

Address

Newsletter

© 2025 by Machinary.com - Version: 1.0.0.0. All rights reserved

Layout

Color mode

Theme mode

Layout settings

Save settings
Reset settings